These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 1497621)

  • 1. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts.
    D'Agrosa RM; Hubbes M; Zhang S; Shankaran R; Callahan JW
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):833-8. PubMed ID: 1497621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.
    Okamura-Oho Y; Zhang S; Hilson W; Hinek A; Callahan JW
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):787-94. PubMed ID: 8611156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular form and subcellular distribution of acid beta-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis.
    Takiyama N; Itoh K; Shimmoto M; Nishimoto J; Inui K; Sakuraba H; Suzuki Y
    Brain Dev; 1997 Mar; 19(2):126-30. PubMed ID: 9105659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
    Hinek A; Zhang S; Smith AC; Callahan JW
    Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme.
    Hubbes M; D'Agrosa RM; Callahan JW
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):827-31. PubMed ID: 1497620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
    Balestrin RC; Baldo G; Vieira MB; Sano R; Coelho JC; Giugliani R; Matte U
    Braz J Med Biol Res; 2008 Apr; 41(4):283-8. PubMed ID: 18392450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.
    Callahan JW
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
    Chen JC; Luu AR; Wise N; Angelis R; Agrawal V; Mangini L; Vincelette J; Handyside B; Sterling H; Lo MJ; Wong H; Galicia N; Pacheco G; Van Vleet J; Giaramita A; Fong S; Roy SM; Hague C; Lawrence R; Bullens S; Christianson TM; d'Azzo A; Crawford BE; Bunting S; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13532-13555. PubMed ID: 31481471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.
    Caciotti A; Donati MA; d'Azzo A; Salvioli R; Guerrini R; Zammarchi E; Morrone A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):160-4. PubMed ID: 18571950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis).
    Oshima A; Yoshida K; Itoh K; Kase R; Sakuraba H; Suzuki Y
    Hum Genet; 1994 Feb; 93(2):109-14. PubMed ID: 8112731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts.
    Hossain MA; Higaki K; Shinpo M; Nanba E; Suzuki Y; Ozono K; Sakai N
    Brain Dev; 2016 Feb; 38(2):175-80. PubMed ID: 26259553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.
    Mohamed FE; Al Sorkhy M; Ghattas MA; Al-Gazali L; Al-Dirbashi O; Al-Jasmi F; Ali BR
    Hum Genet; 2020 May; 139(5):657-673. PubMed ID: 32219518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.
    Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H
    Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of carboxypeptidase activity in infantile-onset galactosialidosis.
    Ozand PT; Gascon GG
    J Child Neurol; 1992 Apr; 7 Suppl():S31-40. PubMed ID: 1588013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular heterogeneity in hereditary beta-galactosidase deficiency.
    Suzuki Y; Sakuraba H; Oshima A; Yoshida K; Shimmoto M; Takano T; Fukuhara Y
    Dev Neurosci; 1991; 13(4-5):299-303. PubMed ID: 1817034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.
    van der Spoel A; Bonten E; d'Azzo A
    J Biol Chem; 2000 Apr; 275(14):10035-40. PubMed ID: 10744681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities.
    Kase R; Itoh K; Takiyama N; Oshima A; Sakuraba H; Suzuki Y
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1175-9. PubMed ID: 2244901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.